Topics

DGAP-DD: Epigenomics AG english

06:28 EDT 29 Oct 2019 | EQS Group


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

29.10.2019 / 10:27
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Helge
Last name(s): Lubenow

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Epigenomics AG

b) LEI
549300X1C4U862NDLN97 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Financial instrument linked to a share or a debt instrument
Description: Subscription right, ISIN DE000A255FM4

b) Nature of the transaction
Granting of 4,050 subscription rights as part of a capital increase with subscription rights

c) Price(s) and volume(s)
Price(s) Volume(s)
not numberable not numberable

d) Aggregated information
Price Aggregated volume
not numberable not numberable

e) Date of the transaction
2019-10-24; UTC+1

f) Place of the transaction
Outside a trading venue



29.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Original Article: DGAP-DD: Epigenomics AG english

NEXT ARTICLE

More From BioPortfolio on "DGAP-DD: Epigenomics AG english"

Quick Search